Nutrition Supplement for Cystic Fibrosis
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University
- Study ID
- NCT07163078
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cystic Fibrosis (CF)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Common form supplementation — DIETARY_SUPPLEMENTThe intervention product would represent part of a typical supplement given to people including those with CF
- Uncommon nutrient supplementation — DIETARY_SUPPLEMENTThe intervention product would represent part of a possible new supplement given to people including those with CF
Study Details
The goal of this study is to learn if one nutrition supplement formula works better than a different formula in adults with cystic fibrosis. The main question being addressed is: Will certain atypical versions of certain nutrients outperform typical versions of these nutrients? This will be determined by examining blood measures of nutrient levels and/or indications of nutrient function indicators pre- and post-intervention. Participants will take the supplements for 6 weeks with a blood draw before and after that time.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- May 2026
- Primary completion
- Dec 31, 2026
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Conventional nutrient formsPeople are given a supplement with nutrient forms typically used in supplements
- Experimental: Non-common nutrient formsPeople are given a supplement with nutrient forms that are not the most commonly used forms in supplements
Primary Outcome Measure
Nutrient status assessor 1 [ Time Frame: From pre-supplementation to 6 weeks later ]
Central Contacts
- Stephanie Clinical Research Program Coordinato614-722-2000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Nationwide Children's Hospital-Ohio State University | Columbus | Ohio | 43016 | - |
Find similar trials in Columbus, OH
Related Studies
- TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of AgeRecruiting · State University of New York at Buffalo · Orange, California
- Study to Enable New Diagnostics for Pulmonary Microbes in People With CFNot Yet Recruiting · Chris Goss · La Jolla, California
- Phase 2 Study to Assess the Safety and Efficacy of ANG003PHASE2 · Recruiting · Anagram Therapeutics, Inc. · Long Beach, California
- A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.PHASE2 · Not Yet Recruiting · Aimmune Nestlé Health Science US R&D, LLC · Scottsdale, Arizona